US Stock MarketDetailed Quotes

OBIO Orchestra BioMed

Watchlist
  • 5.300
  • +0.170+3.31%
Close May 22 16:00 ET
189.68MMarket Cap-3672P/E (TTM)

Orchestra BioMed Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-46.74%620K
-21.88%2.76M
-76.25%262K
-63.97%419K
128.18%915K
34.41%1.16M
551.79%3.53M
1.1M
1.16M
401K
Operating revenue
-46.74%620K
-21.88%2.76M
-76.25%262K
-63.97%419K
128.18%915K
34.41%1.16M
551.79%3.53M
--1.1M
--1.16M
--401K
Cost of revenue
-22.73%34K
-11.85%186K
-11.32%47K
-26.79%41K
-10.00%54K
4.76%44K
6.03%211K
53K
56K
60K
Gross profit
-47.68%586K
-22.52%2.57M
-79.52%215K
-65.85%378K
152.49%861K
35.92%1.12M
438.63%3.32M
1.05M
1.11M
341K
Operating expense
18.51%15.01M
50.31%54.08M
16.71%12.7M
33.36%14.9M
73.25%13.82M
112.79%12.67M
72.83%35.98M
10.88M
11.17M
7.98M
Selling and administrative expenses
33.69%5.9M
44.35%20.26M
25.49%4.19M
20.27%6.34M
80.52%5.32M
78.01%4.41M
77.02%14.03M
--3.34M
--5.28M
--2.95M
Research and development costs
10.39%9.11M
54.12%33.82M
12.83%8.51M
45.08%8.56M
69.00%8.5M
137.59%8.25M
70.25%21.95M
--7.54M
--5.9M
--5.03M
Operating profit
-24.93%-14.42M
-57.72%-51.51M
-26.99%-12.48M
-44.27%-14.52M
-69.71%-12.96M
-125.14%-11.55M
-49.81%-32.66M
-9.83M
-10.07M
-7.63M
Net non-operating interest income expense
14.80%1.02M
7,598.00%3.85M
136.25%1.11M
1,352.38%915K
482.52%941K
475.00%885K
105.39%50K
469K
63K
-246K
Non-operating interest income
14.80%1.02M
7,598.00%3.85M
----
----
--941K
--885K
--50K
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--246K
Total other finance cost
----
----
----
-1,352.38%-915K
----
----
----
----
---63K
----
Other net income (expense)
80.00%-56K
-46.15%-1.46M
-269.57%-1.45M
205.40%293K
-193.94%-31K
23.29%-280K
-247.57%-1M
-391K
-278K
33K
Gain on sale of security
83.93%-45K
2.19%-312K
24.81%-294K
205.40%293K
-104.34%-31K
23.29%-280K
-10.76%-319K
---391K
---278K
--715K
Special income (charges)
----
-68.77%-1.15M
---1.15M
--0
--0
----
---682K
--0
--0
---682K
-Less:Other special charges
----
68.77%1.15M
----
----
----
----
--682K
--0
----
--682K
Other non- operating income (expenses)
---11K
----
----
----
----
----
----
----
----
----
Income before tax
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
-10.28M
-7.85M
Income tax
Net income
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
-10.28M
-7.85M
Net income continuous Operations
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
---9.75M
---10.28M
---7.85M
Minority interest income
Net income attributable to the parent company
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
-10.28M
-7.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.06%-13.46M
-46.16%-49.12M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-46.03%-33.61M
-9.75M
-10.28M
-7.85M
Basic earnings per share
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
-16.84%-0.38
-41.01%-0.35
-120.73%-0.4
-46.03%-1.0631
-0.3084
-0.3252
-0.2482
Diluted earnings per share
5.00%-0.38
-39.22%-1.48
-19.97%-0.37
-16.84%-0.38
-41.01%-0.35
-120.73%-0.4
-46.03%-1.0631
-0.3084
-0.3252
-0.2482
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -46.74%620K-21.88%2.76M-76.25%262K-63.97%419K128.18%915K34.41%1.16M551.79%3.53M1.1M1.16M401K
Operating revenue -46.74%620K-21.88%2.76M-76.25%262K-63.97%419K128.18%915K34.41%1.16M551.79%3.53M--1.1M--1.16M--401K
Cost of revenue -22.73%34K-11.85%186K-11.32%47K-26.79%41K-10.00%54K4.76%44K6.03%211K53K56K60K
Gross profit -47.68%586K-22.52%2.57M-79.52%215K-65.85%378K152.49%861K35.92%1.12M438.63%3.32M1.05M1.11M341K
Operating expense 18.51%15.01M50.31%54.08M16.71%12.7M33.36%14.9M73.25%13.82M112.79%12.67M72.83%35.98M10.88M11.17M7.98M
Selling and administrative expenses 33.69%5.9M44.35%20.26M25.49%4.19M20.27%6.34M80.52%5.32M78.01%4.41M77.02%14.03M--3.34M--5.28M--2.95M
Research and development costs 10.39%9.11M54.12%33.82M12.83%8.51M45.08%8.56M69.00%8.5M137.59%8.25M70.25%21.95M--7.54M--5.9M--5.03M
Operating profit -24.93%-14.42M-57.72%-51.51M-26.99%-12.48M-44.27%-14.52M-69.71%-12.96M-125.14%-11.55M-49.81%-32.66M-9.83M-10.07M-7.63M
Net non-operating interest income expense 14.80%1.02M7,598.00%3.85M136.25%1.11M1,352.38%915K482.52%941K475.00%885K105.39%50K469K63K-246K
Non-operating interest income 14.80%1.02M7,598.00%3.85M----------941K--885K--50K------------
Non-operating interest expense --------------------------------------246K
Total other finance cost -------------1,352.38%-915K-------------------63K----
Other net income (expense) 80.00%-56K-46.15%-1.46M-269.57%-1.45M205.40%293K-193.94%-31K23.29%-280K-247.57%-1M-391K-278K33K
Gain on sale of security 83.93%-45K2.19%-312K24.81%-294K205.40%293K-104.34%-31K23.29%-280K-10.76%-319K---391K---278K--715K
Special income (charges) -----68.77%-1.15M---1.15M--0--0-------682K--0--0---682K
-Less:Other special charges ----68.77%1.15M------------------682K--0------682K
Other non- operating income (expenses) ---11K------------------------------------
Income before tax -23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M-10.28M-7.85M
Income tax
Net income -23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M-10.28M-7.85M
Net income continuous Operations -23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M---9.75M---10.28M---7.85M
Minority interest income
Net income attributable to the parent company -23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M-10.28M-7.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.06%-13.46M-46.16%-49.12M-31.47%-12.82M-29.51%-13.32M-53.51%-12.05M-90.96%-10.94M-46.03%-33.61M-9.75M-10.28M-7.85M
Basic earnings per share 5.00%-0.38-39.22%-1.48-19.97%-0.37-16.84%-0.38-41.01%-0.35-120.73%-0.4-46.03%-1.0631-0.3084-0.3252-0.2482
Diluted earnings per share 5.00%-0.38-39.22%-1.48-19.97%-0.37-16.84%-0.38-41.01%-0.35-120.73%-0.4-46.03%-1.0631-0.3084-0.3252-0.2482
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg